Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient

Int J Hematol. 2010 Mar;91(2):347-8; author reply 349. doi: 10.1007/s12185-010-0497-9. Epub 2010 Feb 10.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Aged, 80 and over
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Castleman Disease / drug therapy*
  • Castleman Disease / immunology
  • HIV Seronegativity
  • Herpesvirus 8, Human / isolation & purification
  • Humans
  • Male
  • Remission Induction
  • Rituximab
  • Sarcoma, Kaposi / diagnosis*
  • Sarcoma, Kaposi / immunology
  • Sarcoma, Kaposi / virology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab